Home  »  Hot Stocks   »  Revelation Biosciences Inc. (REVB) Shares Down Des...

Revelation Biosciences Inc. (REVB) Shares Down Despite Recent Market Volatility

Revelation Biosciences Inc. (NASDAQ: REVB)’s stock price has decreased by -14.66 compared to its previous closing price of 1.91. However, the company has seen a -24.88% decrease in its stock price over the last five trading sessions.

Is It Worth Investing in Revelation Biosciences Inc. (NASDAQ: REVB) Right Now?

There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


The average price predicted by analysts for REVB is $15.00, which is $13.37 above the current price. The public float for REVB is 0.54M and currently, short sellers hold a 19.01% ratio of that float. The average trading volume of REVB on March 16, 2023 was 217.51K shares.

REVB’s Market Performance

REVB’s stock has seen a -24.88% decrease for the week, with a -43.01% drop in the past month and a -80.83% fall in the past quarter. The volatility ratio for the week is 19.81%, and the volatility levels for the past 30 days are at 11.85% for Revelation Biosciences Inc. The simple moving average for the last 20 days is -25.76% for REVB stock, with a simple moving average of -87.20% for the last 200 days.

REVB Trading at -70.78% from the 50-Day Moving Average

After a stumble in the market that brought REVB to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -98.38% of loss for the given period.

Volatility was left at 11.85%, however, over the last 30 days, the volatility rate increased by 19.81%, as shares sank -39.63% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -75.50% lower at present.

During the last 5 trading sessions, REVB fell by -24.88%, which changed the moving average for the period of 200-days by -91.34% in comparison to the 20-day moving average, which settled at $2.1420. In addition, Revelation Biosciences Inc. saw -75.50% in overturn over a single year, with a tendency to cut further losses.

Stock Fundamentals for REVB

Equity return is now at value 739.20, with -259.60 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 0.02.


In conclusion, Revelation Biosciences Inc. (REVB) has seen bad performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.